Showing 1 - 3 results of 3 for search 'J. Queiruga-Parada', query time: 0.03s Refine Results
  1. 1
    A randomized, double‐blind, single‐dose study to assess bioequivalence of MB02 biosimilar after manufacturing iteration and reference bevacizumab

    A randomized, double‐blind, single‐dose study to assess bioequivalence of MB02 biosimilar after manufacturing iteration and reference bevacizumab by C. Schwabe, A. Cole, A. Espigares‐Correa, M. E. Beydon, A. Florez‐Igual, J. Queiruga‐Parada

    Published 2023-04-01
    Get full text
    Article
  2. 2
    A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol

    A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lym... by I. García-García, P. Guerra-García, C. Ferreras, A. M. Borobia, A. J. Carcas, J. Queiruga-Parada, J. L. Vicario, I. Mirones, C. Solano, C. Eguizabal, B. Soria, A. Pérez-Martínez

    Published 2021-10-01
    Get full text
    Article
  3. 3
    Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)

    Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) by A. Pérez-Martínez, M. Mora-Rillo, C. Ferreras, P. Guerra-García, B. Pascual-Miguel, C. Mestre-Durán, A.M. Borobia, A.J. Carcas, J. Queiruga-Parada, I. García, E. Sánchez-Zapardiel, M. Gasior, R. De Paz, A. Marcos, J.L. Vicario, A. Balas, M.A. Moreno, C. Eguizabal, C. Solano, J.R. Arribas, R.de Miguel Buckley, R. Montejano, B. Soria

    Published 2021-09-01
    Get full text
    Article

Search Tools: